A61K 31/27
Of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
Official title: of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
A61K31/27 (Of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine) appears on 998 US grants and 1,621 published applications in this corpus.
Search patents in A61K- Granted patents
- 998
- Published applications
- 1,621
- Assignees
- 689
- Inventors
- 2,691
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 8 | 0 |
| 1977 | 4 | 0 |
| 1978 | 6 | 0 |
| 1979 | 2 | 0 |
| 1980 | 3 | 0 |
| 1981 | 0 | 0 |
| 1982 | 2 | 0 |
| 1983 | 1 | 0 |
| 1984 | 4 | 0 |
| 1985 | 2 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 3 | 0 |
| 1989 | 1 | 0 |
| 1990 | 6 | 0 |
| 1991 | 3 | 0 |
| 1992 | 4 | 0 |
| 1993 | 4 | 0 |
| 1994 | 10 | 0 |
| 1995 | 7 | 0 |
| 1996 | 15 | 0 |
| 1997 | 21 | 0 |
| 1998 | 13 | 0 |
| 1999 | 22 | 0 |
| 2000 | 31 | 0 |
| 2001 | 16 | 13 |
| 2002 | 14 | 22 |
| 2003 | 21 | 68 |
| 2004 | 31 | 74 |
| 2005 | 14 | 46 |
| 2006 | 54 | 42 |
| 2007 | 12 | 30 |
| 2008 | 16 | 28 |
| 2009 | 12 | 46 |
| 2010 | 7 | 50 |
| 2011 | 8 | 45 |
| 2012 | 19 | 51 |
| 2013 | 21 | 71 |
| 2014 | 42 | 71 |
| 2015 | 34 | 87 |
| 2016 | 58 | 97 |
| 2017 | 45 | 94 |
| 2018 | 67 | 66 |
| 2019 | 58 | 84 |
| 2020 | 45 | 83 |
| 2021 | 44 | 102 |
| 2022 | 42 | 70 |
| 2023 | 42 | 84 |
| 2024 | 41 | 78 |
| 2025 | 41 | 76 |
| 2026 | 20 | 43 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Therapeutic methods and compositions for treating movement disorders29 Sep 2026US 12,746,231 B2Vima Therapeutics, Inc.
- Piperidine urea derivatives for cancer therapy15 Sep 2026US 12,734,164 B2NeuroPn Therapeutics, Inc.
- Small molecule inhibitors of SARS-CoV-2 viral replication and uses thereof25 Aug 2026US 12,715,896 B2Arizona Board of Regents on Behalf of the University of Arizona
- Valiolamine derivatives as glucosidase inhibitors7 Jul 2026US 12,673,924 B2Emergent Product Development Gaithersburg Inc.
- Therapeutic methods and compositions for treating movement disorders30 Jun 2026US 12,667,562 B2Vima Therapeutics, Inc.
- Treprostinil prodrugs8 Oct 2026US 2026/0306438 A1United Therapeutics Corporation
- Compositions and uses of glp-1-gip receptor agonists8 Oct 2026US 2026/0306588 A1Maison Blaise Labs, LLC
- Method of treating fibrotic-related condition1 Oct 2026US 2026/0294863 A1Yissum Research Development Company of the Hebrew University of Jerusalem
- Therapeutic methods and compositions for treating movement disorders24 Sep 2026US 2026/0284025 A1Vima Therapeutics, Inc.
- Compounds for upregulating utrophin levels in muscle cells and method of application thereof24 Sep 2026US 2026/0284043 A1Peptris Technologies Private Limited
Most cited
By later US patents
- Treatment of damaged bone marrow and dosage units therefor585US 4,938,949 AUniversity of New York · 1990
- Compositions, apparatus and methods for facilitating surgical procedures323US 6,711,436 B1Duke University · 2004
- Modulators of ATP-binding cassette transporters157US 7,495,103 B2Vertex Pharmaceuticals Incorporated · 2009
- Compositions, apparatus and methods for facilitating surgical procedures155US 6,101,412 ADuke University · 2000
- Compositions, apparatus and methods for facilitating surgical procedures146US 6,043,273 ADuke University · 2000